title: Is MARS system enough for A. phalloides-induced liver failure treatment?
abstract: Patients with Amanita phalloides-induced liver failure (LF) have a high mortality, despite significant advances in intensive care management. Our study evaluated the effect of Molecular Absorbents Recirculating System (MARS) comparative with optimal intensive care (OIC) in adults with this condition, in the absence of liver transplantation (LT). Six consecutive patients (women, range 16-61 years) affected by A. phalloides-induced LF were treated with OIC (3 patients) and MARS (3 patients). Laboratory parameters and hepeatic encephalopaty were evaluated 15 min before and 24 hours following each MARS treatment. Three 6-hour sessions per patient were performed in MARS group, with a statistically significant decrease in ammonia (p value 0.011), alaninaminotransferase (ALT) and prothrombin time (PT) (p value 0.004). Two patients had a significant rebound in bilirubin (+116%; p value 0. 04) 24 hours following MARS. Mortality in MARS group was 66.7%. Survival rate in OIC was 0%. Negative prognostic markers: lack of PT and hepatic encephalopaty improvement, rebound in bilirubin, and delay of MARS therapy initiation. No significant adverse reactions occurred during MARS. MARS is an effective depurative therapy in adults with A. phalloides-induced LF, but alone is not enough. Survival is predicted by the results of the initial MARS, amount of mushroom consumed, and time from toxin exposure.
authors.affiliation: Emergency Clinic Hospital, Department of Internal Medicine, University of Medicine and Pharmacy, Iasi, Romania. laurentiusorodoc@yahoo.com
authors.forename: Laurentiu
authors.initials: L
authors.lastname: Sorodoc
authors.forename: Catalina
authors.initials: C
authors.lastname: Lionte
authors.forename: Victorita
authors.initials: V
authors.lastname: Sorodoc
authors.forename: Ovidiu
authors.initials: O
authors.lastname: Petris
authors.forename: Irina
authors.initials: I
authors.lastname: Jaba
mesh_terms: D000293:Adolescent; D000328:Adult; D000545:Amanita; D005112:Extracorporeal Circulation / Q000379:methods*; D005260:Female; D015600:Glasgow Coma Scale; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D017114:Liver Failure, Acute / Q000209:etiology / Q000628:therapy*; D008875:Middle Aged; D009145:Mushroom Poisoning / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006435:Renal Dialysis; D012189:Retrospective Studies; D016060:Sorption Detoxification / Q000379:methods*; D016896:Treatment Outcome